|
|
(03) Biomarker Discovery and Validation
Topics in the table below that are marked with an asterisk (*) have been designated as the Institute, Center or Office’s highest priority; however, applicants may apply to any of the topics.
| Challenge Topic ID |
Specific Challenge Topic |
Contact |
| 03-OD-101 |
Use of epigenetic signatures in blood cells to predict disease. Although epigenomic changes appear to be important in many diseases, disease diagnosis may be quite challenging if epigenomic analysis of tissues that are not readily accessible (brain, heart, etc) is required. Blood cells are readily accessible and could serve as powerful "sentinels" or biomarkers for a variety of complex diseases. Characterization of epigenomic signatures in blood cells in a variety of disease situations could lead to the development of entirely new non-invasive diagnostic strategies. |
Dr. Phil Smith (NIDDK)
301-594-8816
smithp@mail.nih.gov |
Up to Top
|
